Sectors
CRBU
Caribou Biosciences, Inc.
1.54
2 x 1.16
1 x 1.56
bid
ask
-
0.08
4.94%
2 @ 05:34 PM
1.55 +0.01 (0.70%)
| Ytd | -3.14% | |
| 1y | -17.65% |
1.52
day range
1.63
1.38
52 week range
3.54
| Open | 1.63 | Prev Close | 1.62 | Low | 1.52 | High | 1.63 | Mkt Cap | 165.10M |
| Vol | 1.01M | Avg Vol | 1.76M | EPS | -1.08 | P/E | N/A | Forward P/E | -0.90 |
| Beta | 2.26 | Short Ratio | 4.55 | Inst. Own | 62.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 1.67 | 200-d Avg | 1.80 | 1yr Est | 12.50 |
| Income Statement | |||
| Operating Expenses | 26.84M | ||
| Research and Development Expense | 18.94M | ||
| Selling, General and Administrative Expense | 7.90M | ||
| Operating Income | -26.84M | ||
| Net Income | -24.28M | ||
| Net Income Common Stock | -24.28M | ||
| Net Income Common Stock (USD) | -24.28M | ||
| Consolidated Income | -24.28M | ||
| Earnings per Basic Share | -0.24 | ||
| Earnings per Basic Share (USD) | -0.24 | ||
| Earnings per Diluted Share | -0.24 | ||
| Earning Before Interest & Taxes (EBIT) | -24.28M | ||
| Earning Before Interest & Taxes (USD) | -24.28M | ||
| Weighted Average Shares | 100.99M | ||
| Weighted Average Shares Diluted | 100.99M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.19M | ||
| Cash and Equivalents (USD) | 26.19M | ||
| Investments | 87.62M | ||
| Investments Current | 86.12M | ||
| Investments Non-Current | 1.50M | ||
| Trade and Non-Trade Receivables | 1.34M | ||
| Current Assets | 116.60M | ||
| Property, Plant & Equipment Net | 22.53M | ||
| Total Assets | 142.77M | ||
| Debt Current | 1.38M | ||
| Total Debt | 26.66M | ||
| Current Liabilities | 17.97M | ||
| Debt Non-Current | 25.28M | ||
| Total Liabilities | 44.67M | ||
| Accumulated Retained Earnings (Deficit) | -645.88M | ||
| Accumulated Other Comprehensive Income | -71.00K | ||
| Shareholders Equity | 98.10M | ||
| Shareholders Equity (USD) | 98.10M | ||
| Assets Non-Current | 26.18M | ||
| Total Debt (USD) | 26.66M | ||
| Deferred Revenue | 1.79M | ||
| Liabilities Non-Current | 26.70M | ||
| Trade and Non-Trade Payables | 3.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 946.00K | ||
| Net Cash Flow from Financing | 17.94M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 14.09M | ||
| Capital Expenditure | -1000 | ||
| Issuance (Purchase) of Equity Shares | 17.94M | ||
| Net Cash Flow from Investing | 18.94M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 18.94M | ||
| Net Cash Flow from Operations | -22.79M | ||
| Share Based Compensation | 2.48M | ||